Next Article in Journal
Antibiotic Activity of Actinobacteria from the Digestive Tract of Millipede Nedyopus dawydoffiae (Diplopoda)
Next Article in Special Issue
Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin
Previous Article in Journal
Explorative Study on Isolation and Characterization of a Microviridae G4 Bacteriophage, EMCL318, against Multi-Drug-resistant Escherichia coli 15-318
Previous Article in Special Issue
Microbiome Analysis of Biofilms of Silver Nanoparticle-Dispersed Silane-Based Coated Carbon Steel Using a Next-Generation Sequencing Technique
Article Menu

Export Article

Open AccessReview
Antibiotics 2018, 7(4), 93; https://doi.org/10.3390/antibiotics7040093

Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017)

1
School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia
2
ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland, Brisbane, QLD 4072, Australia
3
Institute of Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia
*
Author to whom correspondence should be addressed.
Received: 20 August 2018 / Revised: 8 October 2018 / Accepted: 16 October 2018 / Published: 26 October 2018
(This article belongs to the Special Issue Silver-Based Antimicrobials)
Full-Text   |   PDF [8626 KB, uploaded 26 October 2018]   |  

Abstract

The use of silver to control infections was common in ancient civilizations. In recent years, this material has resurfaced as a therapeutic option due to the increasing prevalence of bacterial resistance to antimicrobials. This renewed interest has prompted researchers to investigate how the antimicrobial properties of silver might be enhanced, thus broadening the possibilities for antimicrobial applications. This review presents a compilation of patented products utilizing any forms of silver for its bactericidal actions in the decade 2007–2017. It analyses the trends in patent applications related to different forms of silver and their use for antimicrobial purposes. Based on the retrospective view of registered patents, statements of prognosis are also presented with a view to heightening awareness of potential industrial and health care applications. View Full-Text
Keywords: antibiotic resistance; antimicrobial activity; medicinal silver; patents; silver; silver nanoparticles; synergism antibiotic resistance; antimicrobial activity; medicinal silver; patents; silver; silver nanoparticles; synergism
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Sim, W.; Barnard, R.T.; Blaskovich, M.; Ziora, Z.M. Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017). Antibiotics 2018, 7, 93.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top